Read More Pharma Industry News Glenmark Pharmaceuticals secures US FDA approval for Clindamycin Phosphate Foam, 1% generic Glenmark Pharmaceuticals wins US FDA approval for its generic Clindamycin Phosphate Foam, 1%, expanding its US dermatology portfolio with a new acne treatment option. bySrinathSeptember 21, 2021